rabbit anti zo 2 antibody Search Results


99
Thermo Fisher rabbit zo 2
Rabbit Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit zo 2/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
rabbit zo 2 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

86
Thermo Fisher rabbit polyclonals against zo2
Rabbit Polyclonals Against Zo2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonals against zo2/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
rabbit polyclonals against zo2 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti zo 2
Anti Zo 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti zo 2/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti zo 2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

86
Thermo Fisher polyclonal rabbit anti zo 2 antibody no 71 1400
Characteristics of primers, RT-PCR protocol and antibodies
Polyclonal Rabbit Anti Zo 2 Antibody No 71 1400, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti zo 2 antibody no 71 1400/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
polyclonal rabbit anti zo 2 antibody no 71 1400 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology rabbit anti zo 2 antibody
Characteristics of primers, RT-PCR protocol and antibodies
Rabbit Anti Zo 2 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti zo 2 antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
rabbit anti zo 2 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
Thermo Fisher rabbit anti–zo-2 pab
Characteristics of primers, RT-PCR protocol and antibodies
Rabbit Anti–Zo 2 Pab, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti–zo-2 pab/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
rabbit anti–zo-2 pab - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher anti-rabbit zona occluding-2
Characteristics of primers, RT-PCR protocol and antibodies
Anti Rabbit Zona Occluding 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-rabbit zona occluding-2/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-rabbit zona occluding-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology antibodies against zo2 (santa cruz biotechnology sc-11448, rabbit igg
Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus . Immunofluorescence stainings were performed with antibodies against ZO1, <t>ZO2,</t> occludin, or E-cadherin for determination of the degradation of these TJ proteins. The presented pictures are representative of the results of at least three independent experiments. Scale bar is 25 μm
Antibodies Against Zo2 (Santa Cruz Biotechnology Sc 11448, Rabbit Igg, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against zo2 (santa cruz biotechnology sc-11448, rabbit igg/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
antibodies against zo2 (santa cruz biotechnology sc-11448, rabbit igg - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology zo2
Fig. 4 Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus. Immunofluores- cence stainings were performed with antibodies against ZO1, <t>ZO2,</t> occludin, or E-cadherin for determination of the degradation of these TJ proteins. The present- ed pictures are representative of the results of at least three inde- pendent experiments. Scale bar is 25 μm
Zo2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zo2/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
zo2 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

86
Thermo Fisher rabbit anti zo 2
Fig. 4 Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus. Immunofluores- cence stainings were performed with antibodies against ZO1, <t>ZO2,</t> occludin, or E-cadherin for determination of the degradation of these TJ proteins. The present- ed pictures are representative of the results of at least three inde- pendent experiments. Scale bar is 25 μm
Rabbit Anti Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti zo 2/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
rabbit anti zo 2 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit polyclonal anti-zo-2 (h-110) antibody
(A) Representative images of DNA, YAP, and <t>ZO-2</t> at the lateral plane in MDCK cells under different cell-density conditions. Scale bar, 25 µm. (B) Representative images of ZO-2 depleted cells at confluent cell density 72 hours after seeding. Distributions of DNA, E-cadherin, YAP, and ZO-1 are shown as X-Y views (ZO-1 is at the apical plane, and all others at the lateral plane), and those of YAP, DNA, and gp135 are shown as cross-sectional views. Scale bar, 25 µm. (C) Representative immunoblotting images for ZO-2 and GAPDH from extracts of ZO-2 depleted cells. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm in cells shown in (B). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells for each condition. p -values; student’s t-test. (E) Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), GAPDH, histone H3 (H3), and S10-phosphorylated histone H3 (pH3 S10) from extracts of control cells and ZO-2 depleted cells at different cell densities.
Rabbit Polyclonal Anti Zo 2 (H 110) Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-zo-2 (h-110) antibody/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-zo-2 (h-110) antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher zo-2
(A) Representative images of DNA, YAP, and <t>ZO-2</t> at the lateral plane in MDCK cells under different cell-density conditions. Scale bar, 25 µm. (B) Representative images of ZO-2 depleted cells at confluent cell density 72 hours after seeding. Distributions of DNA, E-cadherin, YAP, and ZO-1 are shown as X-Y views (ZO-1 is at the apical plane, and all others at the lateral plane), and those of YAP, DNA, and gp135 are shown as cross-sectional views. Scale bar, 25 µm. (C) Representative immunoblotting images for ZO-2 and GAPDH from extracts of ZO-2 depleted cells. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm in cells shown in (B). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells for each condition. p -values; student’s t-test. (E) Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), GAPDH, histone H3 (H3), and S10-phosphorylated histone H3 (pH3 S10) from extracts of control cells and ZO-2 depleted cells at different cell densities.
Zo 2, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zo-2/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
zo-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of primers, RT-PCR protocol and antibodies

Journal: BMC Gastroenterology

Article Title: Role of tight junction proteins in gastroesophageal reflux disease

doi: 10.1186/1471-230X-12-128

Figure Lengend Snippet: Characteristics of primers, RT-PCR protocol and antibodies

Article Snippet: ZO-2 , fw: AGAGGACACGCCGAGCAGATTG rv: TCCCGACATCATTGCCACCAG 272 bp, 60°C , polyclonal rabbit anti-ZO-2 antibody No. 71–1400, (Invitrogen, Carlsbad, CA, USA, EDTA retrieval, Final dilution: 1:150.

Techniques: Sequencing

Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus . Immunofluorescence stainings were performed with antibodies against ZO1, ZO2, occludin, or E-cadherin for determination of the degradation of these TJ proteins. The presented pictures are representative of the results of at least three independent experiments. Scale bar is 25 μm

Journal: Journal of Molecular Medicine (Berlin, Germany)

Article Title: Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis

doi: 10.1007/s00109-014-1246-y

Figure Lengend Snippet: Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus . Immunofluorescence stainings were performed with antibodies against ZO1, ZO2, occludin, or E-cadherin for determination of the degradation of these TJ proteins. The presented pictures are representative of the results of at least three independent experiments. Scale bar is 25 μm

Article Snippet: Samples were washed and incubated overnight at 4 °C with antibodies against ZO1 (Invitrogen 40-2300, rabbit IgG), ZO2 (Santa Cruz Biotechnology Inc. sc-11448, rabbit IgG), occludin (71-1500, rabbit IgG, Invitrogen), or E-cadherin (Santa Cruz Biotechnology Inc. sc-7870, rabbit IgG).

Techniques: Infection, Immunofluorescence

Fig. 4 Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus. Immunofluores- cence stainings were performed with antibodies against ZO1, ZO2, occludin, or E-cadherin for determination of the degradation of these TJ proteins. The present- ed pictures are representative of the results of at least three inde- pendent experiments. Scale bar is 25 μm

Journal: Journal of molecular medicine (Berlin, Germany)

Article Title: Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis.

doi: 10.1007/s00109-014-1246-y

Figure Lengend Snippet: Fig. 4 Endothelial cells were infected for 2 h with S. aureus (MOI 10:1) or left uninfected. As indicated, cells were pretreated for 20 min with amitriptyline (Ami) (20 μM), Tiron (10 mM), or NAC (10 mM) before infection with S. aureus. Immunofluores- cence stainings were performed with antibodies against ZO1, ZO2, occludin, or E-cadherin for determination of the degradation of these TJ proteins. The present- ed pictures are representative of the results of at least three inde- pendent experiments. Scale bar is 25 μm

Article Snippet: Samples were washed and incubated overnight at 4 °C with antibodies against ZO1 (Invitrogen 40-2300, rabbit IgG), ZO2 (Santa Cruz Biotechnology Inc. sc-11448, rabbit IgG), occludin (71-1500, rabbit IgG, Invitrogen), or E-cadherin (Santa Cruz Biotechnology Inc. sc-7870, rabbit IgG).

Techniques: Infection

(A) Representative images of DNA, YAP, and ZO-2 at the lateral plane in MDCK cells under different cell-density conditions. Scale bar, 25 µm. (B) Representative images of ZO-2 depleted cells at confluent cell density 72 hours after seeding. Distributions of DNA, E-cadherin, YAP, and ZO-1 are shown as X-Y views (ZO-1 is at the apical plane, and all others at the lateral plane), and those of YAP, DNA, and gp135 are shown as cross-sectional views. Scale bar, 25 µm. (C) Representative immunoblotting images for ZO-2 and GAPDH from extracts of ZO-2 depleted cells. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm in cells shown in (B). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells for each condition. p -values; student’s t-test. (E) Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), GAPDH, histone H3 (H3), and S10-phosphorylated histone H3 (pH3 S10) from extracts of control cells and ZO-2 depleted cells at different cell densities.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A) Representative images of DNA, YAP, and ZO-2 at the lateral plane in MDCK cells under different cell-density conditions. Scale bar, 25 µm. (B) Representative images of ZO-2 depleted cells at confluent cell density 72 hours after seeding. Distributions of DNA, E-cadherin, YAP, and ZO-1 are shown as X-Y views (ZO-1 is at the apical plane, and all others at the lateral plane), and those of YAP, DNA, and gp135 are shown as cross-sectional views. Scale bar, 25 µm. (C) Representative immunoblotting images for ZO-2 and GAPDH from extracts of ZO-2 depleted cells. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm in cells shown in (B). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells for each condition. p -values; student’s t-test. (E) Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), GAPDH, histone H3 (H3), and S10-phosphorylated histone H3 (pH3 S10) from extracts of control cells and ZO-2 depleted cells at different cell densities.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Whisker Assay

Representative images of MDCK cells and those depleted of ZO-2 at the low cell density. The distributions of DNA and YAP are shown as X-Y views. Scale bar, 10 µm.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: Representative images of MDCK cells and those depleted of ZO-2 at the low cell density. The distributions of DNA and YAP are shown as X-Y views. Scale bar, 10 µm.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques:

(A and B) ZO-2 is required to maintain the levels of LATS1 protein at high cell density. (A) Representative immunoblotting images for ZO-2, endogenous LATS1 (longer exposure: LE, shorter exposure: SE), S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control and ZO-2 depleted cells. (B) FLAG-LATS1 and HA-ZO-2 immunoblotting images from control and ZO-2 depleted cells with or without ZO-2 transgene are shown. (C) Lats1 mRNA abundance is unaffected by ZO-2 knockdown. The graph depicts the levels of Lats1 mRNA (normalized to those of Gapdh mRNA) measured by RT-qPCR. Plots represent mean values ± s.d. from three independent experiments. p -values; Mann-Whitney test. (D) ZO-2 limits poly-ubiquitination of LATS1 in cells at high density. Representative immunoblotting images for poly-ubiquitin moiety, FLAG-LATS-1, HA-ZO-2, and GAPDH from the FLAG-LATS1 immuno-precipitates are shown. FLAG-LATS1 were immune-precipitated from extracts of control and ZO-2 depleted cells with or without ZO-2 transgene. (E) Inhibition of poly-ubiquitination increases the LATS1 protein level in ZO-2-depleted cells. Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control cells, and ZO-2 depleted cells with or without the expression of HA-ubiquitin K0 are shown. (F) Inhibition of proteasome activity increases the LATS1 protein level in ZO-2 depleted cells. Representative immunoblotting images for ZO-2, LATS1, and S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control cells, and ZO-2 depleted cells with or without MG132 treatment are shown. (G) A model of proteasome-mediated degradation of LATS1. ZO-2 antagonizes with poly-ubiquitination and degradation of LATS1. (H) Increased levels in LATS1 protein is insufficient for the restoration of nuclear-to-cytoplasm translocation of YAP in ZO-2 depleted cells. Left: representative images of cells depleted of ZO-2 with or without MG132 treatment. Right: representative images of ZO-2 depleted cells with FLAG-ZO-2 transgene after MG132 treatment. The distributions of YAP were visualized 72 hours after seeding. Scale bar, 25 µm. (I) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm from cells shown in (F). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 71, 37, 62 cells for each condition. p -values; student’s t-test.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A and B) ZO-2 is required to maintain the levels of LATS1 protein at high cell density. (A) Representative immunoblotting images for ZO-2, endogenous LATS1 (longer exposure: LE, shorter exposure: SE), S909-phosphorylated LATS1 (pLATS S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control and ZO-2 depleted cells. (B) FLAG-LATS1 and HA-ZO-2 immunoblotting images from control and ZO-2 depleted cells with or without ZO-2 transgene are shown. (C) Lats1 mRNA abundance is unaffected by ZO-2 knockdown. The graph depicts the levels of Lats1 mRNA (normalized to those of Gapdh mRNA) measured by RT-qPCR. Plots represent mean values ± s.d. from three independent experiments. p -values; Mann-Whitney test. (D) ZO-2 limits poly-ubiquitination of LATS1 in cells at high density. Representative immunoblotting images for poly-ubiquitin moiety, FLAG-LATS-1, HA-ZO-2, and GAPDH from the FLAG-LATS1 immuno-precipitates are shown. FLAG-LATS1 were immune-precipitated from extracts of control and ZO-2 depleted cells with or without ZO-2 transgene. (E) Inhibition of poly-ubiquitination increases the LATS1 protein level in ZO-2-depleted cells. Representative immunoblotting images for ZO-2, LATS1, S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control cells, and ZO-2 depleted cells with or without the expression of HA-ubiquitin K0 are shown. (F) Inhibition of proteasome activity increases the LATS1 protein level in ZO-2 depleted cells. Representative immunoblotting images for ZO-2, LATS1, and S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of control cells, and ZO-2 depleted cells with or without MG132 treatment are shown. (G) A model of proteasome-mediated degradation of LATS1. ZO-2 antagonizes with poly-ubiquitination and degradation of LATS1. (H) Increased levels in LATS1 protein is insufficient for the restoration of nuclear-to-cytoplasm translocation of YAP in ZO-2 depleted cells. Left: representative images of cells depleted of ZO-2 with or without MG132 treatment. Right: representative images of ZO-2 depleted cells with FLAG-ZO-2 transgene after MG132 treatment. The distributions of YAP were visualized 72 hours after seeding. Scale bar, 25 µm. (I) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm from cells shown in (F). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 71, 37, 62 cells for each condition. p -values; student’s t-test.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Quantitative RT-PCR, MANN-WHITNEY, Inhibition, Expressing, Activity Assay, Translocation Assay, Whisker Assay

(A) Diagrammatic representation of HA-tagged ZO-2 fragments used in (B). (B) Representative images of MDCK cells expressing full-length HA-ZO-2 or HA-ZO-2[1-590 aa]. Distributions of DNA, HA-ZO-2 fusions, and YAP are shown as X-Y views. The area of nuclei in cells expressing HA-tagged ZO2 are marked by white dotted lines. Scale bar, 25 µm.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A) Diagrammatic representation of HA-tagged ZO-2 fragments used in (B). (B) Representative images of MDCK cells expressing full-length HA-ZO-2 or HA-ZO-2[1-590 aa]. Distributions of DNA, HA-ZO-2 fusions, and YAP are shown as X-Y views. The area of nuclei in cells expressing HA-tagged ZO2 are marked by white dotted lines. Scale bar, 25 µm.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Expressing

(A and B) Representative immunoblotting images for (A) ZO-2 and LATS1, (B) ZO-2 and YAP in the ZO-2 immunoprecipitates. ZO-2 was immunoprecipitated from extracts of cells at different cell-density conditions. Levels of ZO-2, LATS1, YAP, and GAPDH in cell extracts are shown as inputs. (C) ZO-2 stimulates an interaction between LATS1 and YAP at high cell density. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates are shown. FLAG-YAP was immunoprecipitated from extracts of control cells and ZO-2 depleted cells at high density. Levels of ZO-2 and LATS1 in cell extracts are shown as inputs. (D) Diagrammatic representation of HA-tagged ZO-2 fragments used in (E) and (F). (E) ZO-2 associates with LATS1 via the SH3 domain. Representative immunoblotting images for HA-tagged ZO-2 fragments and FLAG-LATS1 in the FLAG-LATS1 immuno-precipitates are shown. FLAG-LATS1 was immunoprecipitated from the extracts of cells expressing various ZO-2 fragments. Levels of HA-ZO-2 fragments and GAPDH in cell extracts are shown as inputs. (F) The interaction between LATS1 and YAP requires the SH3 domain of ZO-2. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates. FLAG-YAP was immunoprecipitated from extracts of ZO-2 depleted cells expressing HA-EV, HA-ZO-2, or HA-ZO-2(ΔSH3). Levels of HA-ZO-2, HA-ZO-2(ΔSH3), LATS1, FLAG-YAP, and GAPDH in cell extracts are shown as inputs. (G and H) LATS1 interacts with ZO-2 through its SH3 domain-binding motifs. Representative immunoblotting images for HA-ZO-2, FLAG-LATS1, and GAPDH in FLAG-LATS1 immunoprecipitates are shown. FLAG-LATS1 fusions were immunoprecipitated from extracts of cells at high density. The levels of HA-ZO-2, FLAG-LATS1, and GAPDH in cell extracts are shown as inputs. (I) ZO-2 acts as a scaffold that associates with both LATS1 and YAP. Representative immunoblotting images for HA-LATS1, HA-ZO-2, and FLAG-YAP in the FLAG-YAP immunoprecipitates. FLAG-YAP was immunoprecipitated from extracts of cells expressing various levels of ZO-2. Levels of HA-ZO-2 and HA-LATS1 in cell extracts are shown as inputs. (J) Diagrammatic representation of the formation of a tripartite complex comprising LATS1–ZO-2–YAP.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A and B) Representative immunoblotting images for (A) ZO-2 and LATS1, (B) ZO-2 and YAP in the ZO-2 immunoprecipitates. ZO-2 was immunoprecipitated from extracts of cells at different cell-density conditions. Levels of ZO-2, LATS1, YAP, and GAPDH in cell extracts are shown as inputs. (C) ZO-2 stimulates an interaction between LATS1 and YAP at high cell density. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates are shown. FLAG-YAP was immunoprecipitated from extracts of control cells and ZO-2 depleted cells at high density. Levels of ZO-2 and LATS1 in cell extracts are shown as inputs. (D) Diagrammatic representation of HA-tagged ZO-2 fragments used in (E) and (F). (E) ZO-2 associates with LATS1 via the SH3 domain. Representative immunoblotting images for HA-tagged ZO-2 fragments and FLAG-LATS1 in the FLAG-LATS1 immuno-precipitates are shown. FLAG-LATS1 was immunoprecipitated from the extracts of cells expressing various ZO-2 fragments. Levels of HA-ZO-2 fragments and GAPDH in cell extracts are shown as inputs. (F) The interaction between LATS1 and YAP requires the SH3 domain of ZO-2. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates. FLAG-YAP was immunoprecipitated from extracts of ZO-2 depleted cells expressing HA-EV, HA-ZO-2, or HA-ZO-2(ΔSH3). Levels of HA-ZO-2, HA-ZO-2(ΔSH3), LATS1, FLAG-YAP, and GAPDH in cell extracts are shown as inputs. (G and H) LATS1 interacts with ZO-2 through its SH3 domain-binding motifs. Representative immunoblotting images for HA-ZO-2, FLAG-LATS1, and GAPDH in FLAG-LATS1 immunoprecipitates are shown. FLAG-LATS1 fusions were immunoprecipitated from extracts of cells at high density. The levels of HA-ZO-2, FLAG-LATS1, and GAPDH in cell extracts are shown as inputs. (I) ZO-2 acts as a scaffold that associates with both LATS1 and YAP. Representative immunoblotting images for HA-LATS1, HA-ZO-2, and FLAG-YAP in the FLAG-YAP immunoprecipitates. FLAG-YAP was immunoprecipitated from extracts of cells expressing various levels of ZO-2. Levels of HA-ZO-2 and HA-LATS1 in cell extracts are shown as inputs. (J) Diagrammatic representation of the formation of a tripartite complex comprising LATS1–ZO-2–YAP.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Immunoprecipitation, Expressing, Binding Assay

(A and B) ZO-2 recruits S909-phosphorylated LATS1 to the apical junctions. Representative distributions of S909-phosphorylated LATS1 (pLATS1 S909) in control cells and ZO-2 depleted cells (A) and ZO-2 depleted cells with FLAG-ZO-2 transgene (B). Scale bar, 25 µm. (C) ZO-2 associates with S909-phosphorylated LATS1. Representative immunoblotting images for S909-phosphorylated LATS1 (pLATS1 S909) and ZO-2 in the ZO-2 immunoprecipitates. ZO-2 was immunoprecipitated from extracts of cells at high density. Levels of pLATS1 S909, ZO-2, and GAPDH in cell extracts are shown as inputs. (D) Representative immunoblotting images for ZO-1, ZO-2, and GAPDH in control cells and ZO-1 depleted cells. (E) ZO-1-dependent tight junctions are essential for the recruitment of ZO-2 and S909-phosphorylated LATS1 to the apical junctions. Representative distributions of ZO-2 and S909-phosphorylated LATS1 (pLATS1 S909) in control cells and ZO-1 depleted cells. Scale bar, 25 µm. (F) ZO-1-dependent tight junction is essential for efficient phosphorylation of LATS1 and YAP. Representative immunoblotting images for ZO-1, LATS1, S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), and GADPH in extracts of control cells and ZO-1 depleted cells are shown. (G) ZO-1-dependent tight junctions are required for effective translocation of YAP from the nucleus to the cytoplasm. Representative distributions of DNA, YAP, and ZO-2 in control cells and ZO-1 depleted cells at high density are shown as X-Y views (top) and cross-sectional views (bottom). Scale bar, 25 µm. (H and I) Quantification of the ratio of YAP intensities (H) and ZO-2 intensities (I) in the nucleus relative to that in the cytoplasm from cells shown in (G). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells (H) and n = 30 cells (I) for each condition. p -values; student’s t-test.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A and B) ZO-2 recruits S909-phosphorylated LATS1 to the apical junctions. Representative distributions of S909-phosphorylated LATS1 (pLATS1 S909) in control cells and ZO-2 depleted cells (A) and ZO-2 depleted cells with FLAG-ZO-2 transgene (B). Scale bar, 25 µm. (C) ZO-2 associates with S909-phosphorylated LATS1. Representative immunoblotting images for S909-phosphorylated LATS1 (pLATS1 S909) and ZO-2 in the ZO-2 immunoprecipitates. ZO-2 was immunoprecipitated from extracts of cells at high density. Levels of pLATS1 S909, ZO-2, and GAPDH in cell extracts are shown as inputs. (D) Representative immunoblotting images for ZO-1, ZO-2, and GAPDH in control cells and ZO-1 depleted cells. (E) ZO-1-dependent tight junctions are essential for the recruitment of ZO-2 and S909-phosphorylated LATS1 to the apical junctions. Representative distributions of ZO-2 and S909-phosphorylated LATS1 (pLATS1 S909) in control cells and ZO-1 depleted cells. Scale bar, 25 µm. (F) ZO-1-dependent tight junction is essential for efficient phosphorylation of LATS1 and YAP. Representative immunoblotting images for ZO-1, LATS1, S909-phosphorylated LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), MST1, T183/T180-phosphorylated MST1/2 (pMST1 T183 / pMST2 T180), and GADPH in extracts of control cells and ZO-1 depleted cells are shown. (G) ZO-1-dependent tight junctions are required for effective translocation of YAP from the nucleus to the cytoplasm. Representative distributions of DNA, YAP, and ZO-2 in control cells and ZO-1 depleted cells at high density are shown as X-Y views (top) and cross-sectional views (bottom). Scale bar, 25 µm. (H and I) Quantification of the ratio of YAP intensities (H) and ZO-2 intensities (I) in the nucleus relative to that in the cytoplasm from cells shown in (G). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 20 cells (H) and n = 30 cells (I) for each condition. p -values; student’s t-test.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Immunoprecipitation, Translocation Assay, Whisker Assay

(A) ZO-1 is dispensable for the formation of LATS1–ZO-2–YAP tripartite complex. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates are shown. FLAG-YAP was immunoprecipitated from extracts of control cells and ZO-1 depleted cells at high density. Levels of ZO-1, LATS1, FLAG-YAP, and GAPDH in cell extracts are shown as inputs. (B-D) Recruitment of tight-junctional proteins, Amot or NF2, to the LATS1-ZO-2-YAP tripartite complex induces efficient phosphorylation of LATS1 and YAP. (B) Diagrammatic representation of artificial recruitment of Amot and NF2 to ZO-2. (C and D) Recruitment of Amot and NF2 to the LATS1-ZO-2-YAP tripartite complex induces efficient nuclear exit of YAP. (C) Representative images of YAP distribution in ZO-1 depleted cells expressing YFP-FRB and CFP-FKBP after AP21967 treatment and in those expressing YFP-ZO-2-FRB and either CFP-FKBP-Amot or CFP-FKBP-NF2 before and after AP21967 treatment are shown. Scale bar, 25 µm. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm from cells shown in (C). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 25, 18, 22, 15, 9, 12 cells for each condition. p -values; Mann-Whitney test.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A) ZO-1 is dispensable for the formation of LATS1–ZO-2–YAP tripartite complex. Representative immunoblotting images for LATS1 and FLAG-YAP in the FLAG-YAP immunoprecipitates are shown. FLAG-YAP was immunoprecipitated from extracts of control cells and ZO-1 depleted cells at high density. Levels of ZO-1, LATS1, FLAG-YAP, and GAPDH in cell extracts are shown as inputs. (B-D) Recruitment of tight-junctional proteins, Amot or NF2, to the LATS1-ZO-2-YAP tripartite complex induces efficient phosphorylation of LATS1 and YAP. (B) Diagrammatic representation of artificial recruitment of Amot and NF2 to ZO-2. (C and D) Recruitment of Amot and NF2 to the LATS1-ZO-2-YAP tripartite complex induces efficient nuclear exit of YAP. (C) Representative images of YAP distribution in ZO-1 depleted cells expressing YFP-FRB and CFP-FKBP after AP21967 treatment and in those expressing YFP-ZO-2-FRB and either CFP-FKBP-Amot or CFP-FKBP-NF2 before and after AP21967 treatment are shown. Scale bar, 25 µm. (D) Quantification of the ratio of YAP intensities in the nucleus relative to that in the cytoplasm from cells shown in (C). Data in box-and-whisker plots show median (midline), 25 th to 75 th percentiles (box), and minimum and maximum (whiskers) from n = 25, 18, 22, 15, 9, 12 cells for each condition. p -values; Mann-Whitney test.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Immunoprecipitation, Expressing, Whisker Assay, MANN-WHITNEY

(A) Representative immunoblotting images for FLAG-ZO-1, HA-ZO-2, HA-MST-1/2, HA-LATS1, and HA-YAP in FLAG-ZO-1 immunoprecipitates. FLAG-ZO-1 was immunoprecipitated from extracts of cells at high density. Levels of FLAG-ZO-1, HA-ZO-2, HA-MST-1/2, HA-LATS1, HA-YAP, and GAPDH from cell extracts are shown as inputs. (B) Representative immunoblotting images for FLAG-MST1, FLAG-YAP, and HA-LATS1 in FLAG immunoprecipitates. FLAG fusions were immunoprecipitated from extracts of cells at high density. Levels of FLAG-MST1, FLAG-YAP, HA-LATS1, and GAPDH from cell extracts are shown as inputs.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A) Representative immunoblotting images for FLAG-ZO-1, HA-ZO-2, HA-MST-1/2, HA-LATS1, and HA-YAP in FLAG-ZO-1 immunoprecipitates. FLAG-ZO-1 was immunoprecipitated from extracts of cells at high density. Levels of FLAG-ZO-1, HA-ZO-2, HA-MST-1/2, HA-LATS1, HA-YAP, and GAPDH from cell extracts are shown as inputs. (B) Representative immunoblotting images for FLAG-MST1, FLAG-YAP, and HA-LATS1 in FLAG immunoprecipitates. FLAG fusions were immunoprecipitated from extracts of cells at high density. Levels of FLAG-MST1, FLAG-YAP, HA-LATS1, and GAPDH from cell extracts are shown as inputs.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Immunoprecipitation

(A) Representative immunoblotting images for LATS1, S909-phosphoryalted LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of ZO-1-depleted cells expressing CFP-FKBP-Amot, CFP-FKBP, YFP-ZO-2-FRB, and YFP-FRB before and after AP21967 treatment are shown. (B) Representative immunoblotting images for LATS1, S909-phosphoryalted LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of ZO-1-depleted cells expressing CFP-FKBP-NF2, CFP-FKBP, YFP-ZO-2-FRB and YFP-FRB before and after AP21967 treatment are shown.

Journal: bioRxiv

Article Title: ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctions

doi: 10.1101/355081

Figure Lengend Snippet: (A) Representative immunoblotting images for LATS1, S909-phosphoryalted LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of ZO-1-depleted cells expressing CFP-FKBP-Amot, CFP-FKBP, YFP-ZO-2-FRB, and YFP-FRB before and after AP21967 treatment are shown. (B) Representative immunoblotting images for LATS1, S909-phosphoryalted LATS1 (pLATS1 S909), YAP, S127-phosphorylated YAP (pYAP S127), and GAPDH from extracts of ZO-1-depleted cells expressing CFP-FKBP-NF2, CFP-FKBP, YFP-ZO-2-FRB and YFP-FRB before and after AP21967 treatment are shown.

Article Snippet: Rabbit polyclonal anti-ZO-2 (H-110) antibody and goat polyclonal anti-ZO-2 (R-19) were purchased from Santa Cruz Biotechnology.

Techniques: Western Blot, Expressing